Document is current

Any future updates will be listed below

Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma

Crossref DOI link: https://doi.org/10.1186/s12885-017-3577-x

Published Online: 2017-08-29

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark